Related references
Note: Only part of the references are listed.5,3′-Dihydroxy-6,7,4′-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells
Ki Mo Kim et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
PI3K/mTOR mediate mitogen-dependent HDAC1 phosphorylation in breast cancer: a novel regulation of estrogen receptor expression
Simona Citro et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2015)
Ruthenium Polypyridyl Complex Inhibits Growth and Metastasis of Breast Cancer Cells by Suppressing FAK signaling with Enhancement of TRAIL-induced Apoptosis
Wenqiang Cao et al.
SCIENTIFIC REPORTS (2015)
Downregulation of miR-133 via MAPK/ERK signaling pathway involved in nicotine-induced cardiomyocyte apoptosis
Lu Wang et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
Extracellular Matrix Protein Laminin Induces Matrix Metalloproteinase-9 in Human Breast Cancer Cell Line MCF-7
Sekhar Pal et al.
CANCER MICROENVIRONMENT (2014)
Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer
Jianghong Wu et al.
CURRENT CANCER DRUG TARGETS (2013)
Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway
Chan-Hun Jung et al.
ONCOLOGY REPORTS (2013)
Matrine Inhibits Breast Cancer Growth Via miR-21/PTEN/Akt Pathway in MCF-7 Cells
Lin-Qiang Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Effect of metformin on the proliferation, migration, and MMP-2 and-9 expression of human umbilical vein endothelial cells
Nilufar Esfahanian et al.
MOLECULAR MEDICINE REPORTS (2012)
The expression and clinical significance of PI3K, pAkt and VEGF in colon cancer
Yinxu Zhang et al.
ONCOLOGY LETTERS (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
RGD-Modified Endostatin Peptide 30 Derived from Endostatin Suppresses Invasion and Migration of HepG2 Cells Through the αvβ3 Pathway
Shuyan Li et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2011)
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Li Ma et al.
NATURE CELL BIOLOGY (2010)
Natural Products and Colon Cancer: Current Status and Future Prospects
Subapriya Rajamanickam et al.
DRUG DEVELOPMENT RESEARCH (2008)
Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor - induced migration of uveal melanoma cells
Mao Ye et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Adjuvant therapy of colon cancer: Current status and future directions
Ki Young Chung et al.
CANCER JOURNAL (2007)
Focal adhesion kinase: A potential target in cancer therapy
Maroesja J. van Nimwegen et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer
Simone Spaderna et al.
GASTROENTEROLOGY (2006)
Matrix metalloproteinases and tumor metastasis
EI Deryugina et al.
CANCER AND METASTASIS REVIEWS (2006)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity
RM Tjin et al.
CANCER RESEARCH (2005)
Mechanisms of disease: inflammatory mediators and cancer prevention
JR Mann et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
The activation of Akt/PKB signaling pathway and cell survival
G Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells
P O-Charoenrat et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
PI3K-Akt pathway: Its functions and alterations in human cancer
M Osaki et al.
APOPTOSIS (2004)
MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells
P Nyberg et al.
JOURNAL OF DENTAL RESEARCH (2002)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Endostatin binds to the catalytic domain of matrix metalloproteinase-2
SJ Lee et al.
FEBS LETTERS (2002)
Inhibition of protein kinase B/Akt: implications for cancer therapy
MM Hill et al.
PHARMACOLOGY & THERAPEUTICS (2002)
The role of collagen-derived proteolytic fragments in angiogenesis
AG Marneros et al.
MATRIX BIOLOGY (2001)
The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation
A Paju et al.
BRITISH JOURNAL OF CANCER (2001)
Generation and degradation of human endostatin proteins by various proteinases
M Ferreras et al.
FEBS LETTERS (2000)